Restoring effective anti-tumor response in Hodgkin lymphoma with nivolumab

Press brief by Anas Younes, MD of the Memorial Sloan Kettering Cancer Center, New York, NY, at the 2016 Annual Meeting of the European Association of Hematology (EHA), held in Copenhagen, Denmark.

Share this video  
9th June 2016